Contrast-induced nephropathy in Covid 19 patients undergoing emergency percutaneous coronary intervention

Basit Öğe Kaydı
dc.authorid0000-0003-1516-1811
dc.authorid0000-0003-1320-9033
dc.authorid0000-0002-4951-6716
dc.contributor.authorDemirçelik, Bora
dc.contributor.authorÖzcan, Özgür Ulaş
dc.contributor.authorYazar, Arzu
dc.contributor.authorSavur, Ümeyir
dc.contributor.authorGüler, Yeliz
dc.contributor.authorHakgör, Aykun
dc.contributor.authorBoztosun, Bilal
dc.date.accessioned2022-07-01T12:39:10Z
dc.date.available2022-07-01T12:39:10Z
dc.date.issued2022
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Kardiyoloji Ana Bilim Dalı
dc.description.abstractBackground: Covid 19 is an infectious disease, which leads to many adverse effects, such as hypercoagulopathy. Since, the number of the emergency percutaneous coronary intervention (PCI) has increased due to this effect during the pandemic, hence the incidence of contrast induced nephropathy(CIN) has rised.The present study aimed to investigate the risk of developing CIN and the risk factors that may cause CIN in COVID-19 patients, who underwent emergency percutaneous coronary intervention (PCI). Materials and methods: A total of 69 patients, who was diagnosed with COVID -19 and underwent emergency PCI were included in the study. CIN was defined as an increase in serum creatinine value above 0.3 mg/dL within 48 hours after coronary angiography. The patients were allocated to the two groups as developing and not developing CIN, respectively. Results: CIN was developed in 25 (36.2%) patients. Diabetes mellitus was detected in 42% (29) of the patients. Diabetes mellitus and lower ejection fractions (EF) were more observed in patients who developed CIN. (for DM p=0.002, for lower EF p-value =0.034). Furthermore, CRP, ferritin and D-dimer levels were higher in patients who developed CIN (p values respectively; p=0.024, p=0.032, p= 0.021) (Table-1) There was no significant difference between the groups with and without CIN in terms of gender, age, albumin, troponin I and hemoglobin values. Additionally, pre-angiography creatinine value was higher and eGFR levels were lower in the CIN group (p values respectively; p=0.028, p=0.015). Conclusion: In the present study, we demonstrated that in COVID -19 patients, who developed CIN had a greater burden of inflammation, greater incidence of DM and also lower ejection fraction. This study should be supported by prospective randomized studies for developing special treatment strategies for COVID-19 patient groups, who need emergency PCI.
dc.identifier.citationDemirçelik, B., Özcan, Ö. U., Yazar, A., Savur, Ü., Güler, Y., Hakgör, A. ... Boztosun, B. (2022). Contrast-induced nephropathy in Covid 19 patients undergoing emergency percutaneous coronary intervention. Acta Medica Mediterranea, 38(3), 1503-1507. http://doi.org/10.19193/0393-6384_2022_3_226
dc.identifier.doi10.19193/0393-6384_2022_3_226
dc.identifier.endpage1507
dc.identifier.issn0393-6384
dc.identifier.issue3
dc.identifier.scopus2-s2.0-85132430071
dc.identifier.scopusqualityQ4
dc.identifier.startpage1503
dc.identifier.urihttp://doi.org/10.19193/0393-6384_2022_3_226
dc.identifier.urihttps://hdl.handle.net/20.500.12511/9553
dc.identifier.volume38
dc.identifier.wos000820966400012en_US
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.institutionauthorDemirçelik, Bora
dc.institutionauthorÖzcan, Özgür Ulaş
dc.institutionauthorYazar, Arzu
dc.institutionauthorSavur, Ümeyir
dc.institutionauthorGüler, Yeliz
dc.institutionauthorHakgör, Aykun
dc.institutionauthorBoztosun, Bilal
dc.language.isoen
dc.publisherA. CARBONE Editore
dc.relation.ispartofActa Medica Mediterraneaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.subjectContrast-Induced Nephropathy
dc.subjectCoronary Artery Disease
dc.subjectCoronary Intervention
dc.subjectCOVID-19
dc.titleContrast-induced nephropathy in Covid 19 patients undergoing emergency percutaneous coronary intervention
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
Demircelik-Bora-2022.pdf
Boyut:
422.87 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Makale Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu